Tomasz Kaczyński

Partner

"The most important thing is day-to-day relations with a client, guaranteeing solid, reliable support not only in crisis situations but also on a daily basis."

vcard +48 22 557 86 33     tomasz.kaczynski@dzp.pl
  • His expertise encompasses all areas of pharmaceutical law - product registration, reimbursement issues, manufacturing, distribution, parallel import, advertising law and clinical trial issues - he focuses particularly on creating distribution structure in the pharmaceutical market.
  • Advises over 40 companies operating on the pharmaceutical market, including manufacturers, distributors and pharmacy chains.
  • Specialises in food law, in particular regulations applicable to FSMP and dietary supplements.
  • Advises clients on structuring distribution strategies, preventing antitrust agreements and abuse of dominant position, consumer protection law, and combating unfair competition.
  • His experience also includes advising clients on the feed market and GMO food regulation and participation in inspection proceedings on the agri- food market.
  • Previously he worked on public health issues in local administrative authorities where he was responsible e.g. for restructuring public health care centres in Mazowieckie Voivodship.
  • Expert Council Member in the Polish Council for Supplements and Nutritional Foods (KRSiO).
  • Member of the Regional Chamber of Legal Advisers in Warsaw.

artículos asociados

Legal 500 EMEA 2019 recomienda a DZP

Actualidad | 11.04.2019

Acaba de publicarse la nueva edición del ranking Legal 500 EMEA. Tenemos el placer de informarles que DZP y sus especialistas nuevamente han sido distinguidos. Nuestro despacho es líder en las categorías: Dispute Resolution, Energy & Natural Resources, Public Law y Healthcare and Life Sciences.

texto completo

Medicinal product regulation and product liability in Poland: overview

Publicacion | 14.06.2018

The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability.

texto completo

Pharmaceutical IP and competition law in Poland: overview

Publicacion | 14.06.2018

The Q&A gives a high level overview of key issues including patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports.

texto completo

Medicinal product regulation and product liability in Poland

Publicacion | 01.07.2017

The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability.

texto completo

Pharmaceutical IP and competition law in Poland: overview

Publicacion | 01.07.2017

The Q&A gives a high level overview of key issues including patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports.

texto completo

Distribution and marketing of drugs in Poland: overview

Publicacion | 01.11.2016

Overview of distribution and marketing of drugs law (pre-conditions for distribution, licensing, wholesale distribution, marketing to consumers and professionals and engagement with patient organisations).

texto completo

Commercialisation of healthcare in Poland: overview

Publicacion | 01.11.2016

Overview of the regulatory framework for the commercialisation of medical products in Poland (requirements for drugs, medical devices, biological products and natural health products).

texto completo

Michał Czarnuch y Tomasz Kaczyński, socios de DZP

Actualidad | 01.07.2016

Tenemos el placer de informarles de que Michał Czarnuch y Tomasz Kaczyński, vinculados desde hace años al Área de Life Sciences, han sido nombrados socios de DZP con efectos desde el 1 de julio.

texto completo

Commercialisation of Healthcare (Poland)

Publicacion | 15.03.2013

Overview of the regulatory framework for the commercialisation of medical products in Poland (requirements for drugs, medical devices, biological products and natural health products).

texto completo